• You are using an outdated browser. Please upgrade your browser to improve your experience and security.

    20 Under 40: Young Shapers of the Future (Health and Medicine)

    Facebook Twitter

    The future is unwritten. It is also right around the corner, and, if, as science fiction author William Gibson noted, it is not evenly distributed, more and more young people around the world are reaching toward it to shape it, improve it, and make it more equitable. These “shapers of the future” work in many fields and endeavors, embracing every corner and intersection of health and medicine, science and technology, and business and entrepreneurship. They are people of ideas, framing the intellectual questions and concerns that will guide future thought. They are scholars, builders, designers, architects, artists, teachers, writers, musicians, and social and political leaders. While under the age of 40 (as of January 2021), the 200 shapers of the future that we will highlight in this series have already left their mark on the present, and we expect to see much more invention, innovation, creation, and interpretation from them in times to come.


    • Trevor Bedford (38)

      A graduate of the University of Chicago, where he received a bachelor’s degree in biological sciences, and of Harvard University, with a doctorate in biology, Trevor Bedford is a biostatistician, computational biologist, and epidemiologist who uses powerful computing tools and large data sets to study how viruses spread. An associate professor at the Fred Hutchinson Cancer Research Center in Seattle, he works on identifying the genetic evolution of infectious diseases and how that evolution figures with human behavior and geography. He has worked with seasonal flus, Zika, AIDS, and many other maladies. When SARS-CoV-2 arrived in the United States early in 2020, he pivoted, using his statistical methods—including an open-source platform that he helped to develop—to track the movement of COVID–19 across the country, developing visual representations of viral spread. He is a strong advocate of collaborative transparent science involving citizen knowledge, and he has more than 250,000 Twitter followers.

    • Lurit Bepo (32)

      Lurit Bepo was born in Khartoum, the capital of Sudan, in 1990. Her first name, she explains, “is a name from my family’s Bari ethnic group that is traditionally given to the first born female into the family.” With her mother and four siblings, she immigrated to the United States when she was six years old, joining her father, who had been living in Texas and studying for a master’s degree in electrical engineering. After completing a degree in biology and anthropology from Washington University in St. Louis, she entered the joint master’s of public health/doctor of medicine program at Emory University in Atlanta. A resident at San Francisco General Hospital and Trauma Center, she is working in internal medicine, but, she says, “my ideal goal is to move into the health policy world.”

    • Audrey L. Blewer (36)

      Audrey Blewer had an early interest in history, concentrating on Latin America at the University of Florida in Gainesville. Along the way, though, she took an interest in public health and switched to that discipline for her master’s degree at the school, studying the health of imprisoned women. She went on to earn a Ph.D. in epidemiology at the University of Pennsylvania. She is now an assistant professor of family medicine and community health at Duke University School of Medicine. Her recent studies in cardiopulmonary resuscitation (CPR) incidents, the subject of her dissertation, have shown that women receive it less often than men, leading to the development of a CPR dummy with breasts for professional and civilian training. Her further studies suggest that CPR training dissemination strategies can be expanded and better fitted to address geographic, racial, and socioeconomic disparities in CPR education and delivery, especially at the hands of civilian bystanders.

    • Miguel Villavicencio Camarillo (~32)

      Born in Mexico, Miguel Villavicencio Camarillo earned a doctorate in pharmacology in 2018 from the Center for Research and Advanced Studies (CINVESTAV) of the National Polytechnic Institute in Mexico City. In 2020 he was honored with a Pew Latin American fellowship, which carries with it a postdoctoral grant. He is now at the Zuckerman Institute of Columbia University. His research centers on the brain circuitry involved in the human appetite for sugar—circuitry whose first node is in the gut, from which information about dietary sugars is carried directly to the brain. In experimental conditions, sugars can yield a sufficient reward or sense of pleasure to the brain such that it might one day be used to manage depression; Villavicencio is investigating both how sugar elevates mood and how its absence can conversely trigger anxiety or depression. Villavicencio’s work has implications for a host of biologically based sciences, from neurology to nutrition studies and psychiatry.

    • Habib Frost (30)

      Habib Frost was just 23 when he graduated from the University of Copenhagen’s medical school in 2014—the youngest person to become a physician in Denmark’s history. The same year, he was certified in advanced trauma life support by the American College of Surgeons, and two years later, in 2016, he completed the course in strategic management at the Copenhagen Business School. His education addresses a broad range of interests: not only is he a well-known trauma surgeon, but he is also an entrepreneur and inventor who, in 2014, founded a company called Neurescue, which develops computer-aided medical devices to treat cardiac arrest and hemorrhaging, using a combination of novel medical hardware and software. Frost works at the frontier of technology and medicine, using sensors, robotics, and gene-editing technology. The company’s trademarked Neurescue device is a computer-controlled balloon catheter, which, once inserted into the femoral artery, helps redistribute the blood flow during the process of administering CPR to trauma patients.

    • Rachel Haurwitz (35)

      Rachel Haurwitz grew up in Austin, Texas, where she developed a strong interest in science as a child. She received a bachelor’s degree in biological sciences from Harvard College, then went on to secure a doctorate in molecular and cell biology from the University of California at Berkeley. While at Berkeley she was drawn to the gene-editing technology developed there called CRISPR. In 2012, working with a developer of that technology, she joined Caribou Biosciences, founded as a commercial enterprise by scientists at Berkeley, and became its chief executive officer. CRISPR has since been used to edit genes in plant, animal, and human cells, while revealing many applications, whether modifying plants to become drought-resistant or warding off genetic diseases in humans. Some of the company’s technologies are also being used in livestock production through partnerships with Novartis and other firms. An inventor as well as an entrepreneur, Haurwitz holds several patents covering CRISPR-derived technologies.

    • Manuella Kaster (38)

      Born in Florianópolis, Brazil, Manuella Pinto Kaster received a bachelor of science degree in biology at the Federal University of Santa Catarina (UFSC) there, then went on to complete a doctorate in neuroscience. She did postdoctoral research at the Massachusetts Institute of Technology, the Icahn School of Medicine at Mount Sinai, New York, and the University of Coimbra in Portugal. She is now an assistant professor of biochemistry at UFSC. Her research uses basic science and clinical studies to understand the biological mechanisms associated with stress vulnerability and psychiatric disorders; its specific goal is to identify the biological mechanisms associated with stress and depression and their effects on the neural and immune system. This research has led to a number of significant papers that explore the impact of stress on mood and cognitive dysfunction, disorders that are considered to be at epidemic levels worldwide. She was named a member of the Brazilian Academy of Sciences in 2018.

    • Leen Kawas (35)

      Born in Jordan, Leen Kawas received a doctorate in pharmacy and chemistry from the University of Jordan, having been inspired to enter the healthcare field following the death of a beloved grandmother that was caused by cancer. She moved to the United States to study toxicology and molecular pharmacology at Washington State University, receiving a doctorate in 2011. She then became vice president of research at M3 Biotechnology (later renamed Athira Pharma), a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The company’s aim is to restore neuronal health for those who are afflicted by neurological diseases so that they can regain their memories and return to living happier and more productive lives. In 2014 she became the company’s president and CEO and also completed her studies at the University of Washington’s Foster School of Business. In 2020 Kawas became the first woman in more than 20 years to take a Washington-based company public, having raised more than $100 million in venture capital.

    • Laura Lewis (~33)

      Laura Lewis studied cognitive science at McGill University in Montreal, where she received a bachelor’s degree in 2008; she completed a doctorate in neuroscience at Massachusetts Institute of Tehnology in 2014. As a member of Harvard University’s Society of Fellows, she studied how neural signaling works in sleep and altered states of consciousness and under anesthesia. She has developed advanced methods of using neuroimaging data and computational processing to study how the brain functions under conditions such as neurodegenerative and psychiatric disorders, allowing new ways to measure and analyze brain activity. Now an assistant professor of biomedical engineering at Boston University and the recipient of numerous scholarly awards, she is researching why it is that the brain requires sleep. She has discovered that a major function is to clear out metabolic waste products such as beta-amyloids and proteins by washing them out with cerebrospinal fluid in slow-wave sleep. These waste byproducts are removed less thoroughly as humans age, which may have bearing on the development of Alzheimer and other neurodegenerative diseases. One lesson of her research is that healthy sleep may help protect us from such disorders.

    • Kevin Lyman (28)

      A graduate of Middlesex County Academy for Science, Mathematics, and Engineering in New Jersey, Kevin Lyman completed a bachelor’s degree in computer science at the Rensselaer Polytechnic Institute in Troy, New York, in 2015. While still in college, he founded the Inventors Guild, a think tank where students could earn both money and course credit for developing products and founding technology companies. He went on to one such startup in 2015, becoming an engineer for Enlitic, a San Francisco–based company that uses AI to read radiological scans. He became chief operating officer in 2017 and a year later was named the firm’s chief executive officer. Enlitic’s emphasis includes making more efficient use of computational resources in diagnostic healthcare, developing software tools that better allow physicians and support staff to use the vast body of data collected on patients through images, tests, and medical notes. A new software platform to this end is expected to emerge following a round of venture-capital fundraising in 2020. 

      [Learn who’s determining the future of business and entrepreneurship.]

    • Craig MacLean (~38)

      A native of Canada, Craig MacLean received bachelor of science and doctoral degrees from McGill University before moving to the United Kingdom to do research at Imperial College London. He joined the zoology faculty at the University of Oxford. Now a professor of evolution and microbiology, he heads a laboratory that studies antibiotic resistance. Antibiotics, he notes, have contributed significantly to the health of humans and animals alike by reducing mortality and lowering the costs of bacterial diseases. MacLean’s research focuses on discovering the evolutionary processes connected with this resistance, his fundamental vehicle being Pseudomonas aeruginosa, an opportunistic pathogen associated with postsurgical infection, along with Escherichia coli and other dangerous bacteria. One guiding question that the study raises has been whether it is possible to identify antibiotic treatment strategies that suppress bacteria without selecting for resistance. Antibiotic-resistant disease mortality is expected to surpass cancer mortality by 2050, so the work of MacLean and his associates is of urgent importance.

    • Salome Maswime (37)

      Salome Maswime was born in Limpopo, the rural northernmost province of South Africa, where her father was a professor of theology at the University of Venda. She long aspired to become a doctor, earning a medical degree from the University of KwaZulu-Natal in 2005. She went on to receive a master’s degree and doctorate in obstetrics and gynecology from the University of Witwatersrand in Johannesburg. Her research sought ways to reduce maternal morbidity and mortality from caesarian section–related bleeding during birth—a major cause of maternal deaths on the African continent that, she feared, was being worsened by methods of medical care. In 2018 she was awarded a fellowship from Harvard University and Massachusetts General Hospital, where she expanded her studies to investigate the incidence of stillborn babies with HIV-positive mothers. The following year she became an associate professor and head of global surgery at the University of Cape Town. A pioneer in delivering medical services to remote and underserved populations, she has served as president of the South African Clinician Scientists Society and was honored by South Africa’s President Jacob Zuma. “I am mindful that if we get things right in Africa, the impact of our work could be truly global,” she told The Lancet.

    • Divya Nag (29)

      The eldest child of immigrants from the Indian city of Jaipur, Divya Nag grew up in El Dorado Hills, a suburb of Sacramento, California. Fascinated by science from an early age, she enrolled in junior college at the age of 13, studying mathematics. While still in high school, she became an assistant at a nanomaterials lab at the University of California at Davis, researching how near-microscopic particles could be used to suppress wildfires that ravage California. She enrolled at Stanford University, studying cell biology, but dropped out at the age of 20 to start a company called Stem Cell Theranostics, building on research that she had been doing on regenerating heart cells through the use of stem cells. Her dream, as she recounted, was to develop the ability at the cellular level to repair hearts instantly following a heart attack. She later founded StartX Med, a nonprofit medical innovation accelerator program, which has incubated more than 100 health technology companies and has raised more than $400 million in venture capital funding. Now director of health at Apple, she is an inaugural recipient of the Mic 50 Award, which recognizes outstanding achievement by millennials.

    • Leila Pirhaji (34)

      A native of Iran, Leila Pirhaji received bachelor’s and master’s degrees from the University of Tehran in biotechnology. In 2010 she moved to the United States and earned a doctorate in biological and biosystems engineering from the Massachusetts Institute of Technology; she also studied in MIT’s Sloan Executive Education program. While still in Iran, she developed an algorithm that used gene expression data to predict how those genes would be regulated, with implications for the biomarkers of disease and medical applications. In 2017 she founded the Boston-area firm ReviveMed, an artificial intelligence-driven drug discovery platform that is focused on discovering therapeutics for metabolic diseases such as diabetes and fatty liver diseases. Hitherto, only some 5 percent of metabolites could be measured using existing technologies, but, with the application of machine learning, Pirhaji demonstrated that many more of the body’s 100,000 metabolites could be analyzed. The platform can be used to develop pharmaceutical treatments for other maladies, such as autoimmune disorders.

    • Erin Smith (~35)

      Erin Smith began to take an interest in how the endocrine system works while studying kinesiology and exercise science at New Mexico State University, in Las Cruces. While working as a health educator in Denver, Colorado, she took a master’s degree in nutrition, then moved to New Zealand to undertake doctoral study in endocrinology at the University of Otago in Wellington, fine-tuning her research to investigate what a developing baby experiences while in the womb and how maternal health can be promoted to ward off chronic diseases. Her doctoral research indicates, among other things, that fructose consumption during pregnancy has direct effects on the metabolism of the fetus and subsequent development. Smith is active in several organizations around the developmental origins of diseases, and in 2015 she was invited by the World Health Organization to help prioritize research questions in the study of obesity and metabolic disorders among children and adolescents.

      [Find out more about the people creating the future of architecture, urban studies, and engineering.]

    • Morten Sommer (38)

      Born in Denmark, Morten Sommer is an accomplished entrepreneur and scientist. He received a doctorate in synthetic biology at Harvard University, then went on to join the faculty of the Technical University of Denmark Novo Nordisk Foundation Center for Biosustainability near Copenhagen, where he is now professor of microbiology—a post that he attained at the age of 35, becoming Denmark’s youngest full professor. While developing genomic tools to understand biosynthetic processes, drug resistance, and complex microbial communities through his Bacterial Synthetic Biology section, he has founded numerous companies and holds more than 20 patents. “I’ve always been entrepreneurially inclined,” he told an interviewer. “I’ve been working on business plans, and when going into science, this is something that stuck with me.” His research has bearing on biotechnology, medicine, agriculture, and many other areas, a wide range that reflects his commitment to work that has the broadest possible application and that can be commercialized, an aspect of science in which, he observes, Europe lags behind the United States.

    • Bep Uink (~35)

      A member of the Noongar people, Bep Uink completed her bachelor’s degree, master’s degree, and doctorate, all in psychology, at Murdoch University in Perth, Western Australia. She is a research fellow at the Kulbardi Aboriginal Centre there, with varied interests. One of her projects was to study how cell phone use affected adolescent development, while another lent clinical evidence to the thought that in times of emotional stress an age-mate might be more helpful than a parent in sorting out one’s feelings. She notably focuses on understanding how socially determined disadvantages in income, social class, and other variables affect the social and emotional health of young people and how education can be put to use in improving their sense of well-being. Other areas of interest include the factors that can influence success or failure in the academic careers of young indigenous people as well as the mental health of Aboriginal and Torres Strait Islander LGBTQ youth.

    • Humsa Venkatesh (33)

      The child of immigrants to the United States, Humsa Venkatesh became interested in medicine when an uncle in India died of cancer only a short time after being diagnosed. She studied chemical biology at the University of California, at Berkeley, and received a doctorate from Stanford University in 2017 in oncological biology. She was the lead author of a 2015 paper in the journal Cell that revealed that the growth of tumors could be stimulated by neural activity in the cerebral cortex, indicating that malignant tumors are linked by networks that electrically integrate with the brain and that they use the power of this neural circuitry to enhance their growth. Her postdoctoral research in neurology at Stanford, centering on the microenvironments in which tumors develop and grow, now focuses on how this electrical connection can be rewired. Her goal is to apply her findings to other brain malignancies whose treatment might involve new therapies that can target many kinds of cancer.

    • Sho Yano (29)

      A definitive child prodigy, the son of a Japanese father and a Korean mother, Sho Yano is the youngest person ever to have graduated with a doctorate in medicine from the University of Chicago, having done so at the age of 21—a year or two before most students enter medical school. He had already received a Ph.D. in molecular biology several years earlier, in 2009. Before that, Yano entered college when he was just nine years old, graduating from Loyola University in Chicago summa cum laude at the age of 12. He holds a black belt in tae kwon do and is a concert-level pianist, levels of accomplishment that his younger sister echoed, completing her first bachelor’s degree, in biology, when she was 13 years old and her second, in violin performance, four years later. Now licensed to practice medicine in Illinois and Washington, D.C., Dr. Yano specializes in pediatric neurology.

    • Feng Zhang (39)

      Born in Hebei province, China, to parents who worked in computer science, Feng Zhang moved to the United States when he was 11 years old. He graduated from high school in Des Moines, Iowa, in 2000, then studied chemistry and physics at Harvard College. He received a doctorate in chemistry from Stanford University in 2009. His research focused on neurological bioengineering, using light to control neurons so that neural pathways can be discovered and manipulated. Combined with gene-editing techniques and advances in immunology and other medical disciplines, this engineering is expected one day to be used to treat diseases such as Parkinson’s and other complex neurological disorders. In 2019 Zhang was appointed James and Patricia Poitras Professor of Neuroscience at the Massachusetts Institute of Technology (MIT); he had previously been serving as an investigator at the Howard Hughes Medical Institute in Boston, which he continued while at MIT. He has been awarded numerous prizes and honors for his pathbreaking medical research, including an award from the National Science Foundation recognizing the work of scientists under the age of 35.

      [Discover more people under 40 who are shaping the future.]

    Take advantage of our Presidents' Day bonus!
    Learn More!
    52av永久地址最新